Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00401-013-1169-7 | DOI Listing |
Blood Adv
February 2024
Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy.
Large B-cell lymphoma (LBCL) carrying MYC rearrangement, alone or together with BCL2 and/or BCL6 translocations, have shown a poor prognosis when treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in the HIV population. Scanty data are available on the prevalence and prognostic impact of MYC rearrangements in HIV-associated LBCL. We conducted a retrospective study to evaluate the clinical effect of MYC rearrangement in HIV-associated LBCL.
View Article and Find Full Text PDFMod Pathol
December 2023
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:
Biomedicines
June 2023
Department of Human and Animal Cell Lines, Leibniz-Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Inhoffenstr. 7B, 38124 Braunschweig, Germany.
, and are major oncogenes in B-cell lymphoma. Their aberrant activation frequently occurs via chromosomal translocations which juxtapose light or heavy chain immunoglobulin (IG) genes to and or fuse diverse partner genes with . So-called double-hit lymphomas usually carry and rearrangements, while triple-hit lymphomas additionally bear -fusions.
View Article and Find Full Text PDFBlood Res
June 2023
Department of Haematology, Koç University, Medical Faculty, İstanbul, Turkey.
Background: Central nervous system (CNS) prophylactic options for diffuse large B-cell lymphoma (DLBCL) are administered differently in most centers. Unfortunately, there is still not a consensus on which patients, which regimen, for how many cycles, and when prophylaxis should be administered. Thus, this remains an unmet clinical need.
View Article and Find Full Text PDFWorld J Clin Cases
November 2022
Department of Medicine, Wright State University, Dayton, OH 45409, United States.
Background: Anti-glomerular basement membrane (GBM) disease is a rare rapidly progressive glomerulonephritis, frequently associated with alveolar hemorrhage in the lungs and involving the kidney by crescentic glomerulonephritis. It has been described in association with other glomerulonephritides [such as anti-neutrophilic antibody (ANCA)-glomerulonephritis, membranous nephropathy, and immunoglobulin (Ig)A nephropathy].
Case Summary: Herein we present an unusual case of concurrent anti-GBM disease, ANCA-associated crescentic glomerulonephritis and diffuse proliferative immune complex mediated glomerulonephritis with predominant staining for IgA and C3 by immunofluorescence.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!